Gonorrhea p.3 - 2002 STD Surveillance

STD Surveillance 2002

National Profile

Gonorrhea 1 2 3

Table of Contents

Gonorrhea, page 3

Figure 16. Gonorrhea — Age- and sex-specific rates: United States, 2002

Note: See Table 21.

Figure 17. Gonorrhea — Positivity among 15-24 year old women tested in family planning clinics by state: United States and outlying areas, 2002

*States reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2002, except for Pennsylvania and Puerto Rico which submitted gonorrhea positivity data for April -December 2002 only.

SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention

Figure 18. Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2002

Figure 19. Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2002

Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR= chromosomally mediated tetracycline resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin and tetracycline resistant N. gonorrhoeae.

Figure 20. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2002

Note: Resistant isolates have ciprofloxacin MIC ³ 1 µg/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 µg/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

Figure 21. Gonococcal Isolate Surveillance Project (GISP) — Percent of men with gonorrhea who had a previous gonorrhea infection, 1991–2002

*Data first collected in 1991.
**Data first collected in 1992.

Table of Contents